antagonist decoy receptor for TRAIL/Apo-2L,CD263,cytotoxic TRAIL receptor-3,DCR1,DCR1-TNFR,decoy receptor 1,decoy TRAIL receptor without death domain,LIT,lymphocyte inhibitor of TRAIL,TNF-related apoptosis-inducing ligand receptor 3,TRAIL receptor without an intracellular domain,TRAILR3,TRAIL-R3,TRID,tumor necrosis factor receptor superfamily member 10C,tumor necrosis factor receptor superfamily, member 10c, decoy without an intracellular domain.
Receptor for the cytotoxic ligand TRAIL. Lacks a cytoplasmic death domain and hence is not capable of inducing apoptosis. May protect cells against TRAIL mediated apoptosis by competing with TRAIL-R1 and R2 for binding to the ligand.
The reagent is provided in phosphate buffered saline (PBS) containing 15 mM sodium azide and 0.2% (w/v) high-grade protease free Bovine Serum Albumin (BSA) as a stabilizing agent.
